| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
2,645,760 | 2,246,922 | 1,788,179 | 1,176,891 | 593,312 |
| Cost of Revenue
|
-2,082,515 | -1,824,312 | -1,542,513 | -987,152 | -493,665 |
|
Gross Profit
|
563,245 | 422,610 | 245,666 | 189,739 | 99,647 |
|
Selling, General and Administrative Expenses
|
-351,183 | -298,730 | -188,934 | -217,927 | -115,881 |
|
Research and Development Expenses
|
-203,115 | -216,013 | -173,457 | -195,042 | -124,141 |
|
Operating Income/Expenses
|
-554,298 | -514,743 | -362,391 | -412,969 | -240,022 |
|
Total Operating Profit/Loss
|
8,947 | -92,133 | -116,725 | -223,230 | -140,375 |
| Irregular Income/Expenses
|
-9,197 | -22,873 | 0 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
62,764 | 36,063 | 37,042 | 10,716 | 1,286 |
|
Non-Operating Income/Expenses, Total
|
53,567 | 13,190 | 37,042 | 10,716 | 1,286 |
|
Pretax Income
|
62,514 | -78,943 | -79,683 | -212,514 | -139,089 |
|
Provision for Income Tax
|
385 | 1,627 | -4,212 | 4,620 | 0 |
|
Earnings from Equity Interest, Post-Tax
|
-28,260 | -13,716 | -777 | 0 | 0 |
|
Net Income from Continuing Operations
|
34,639 | -91,032 | -84,672 | -207,894 | -139,089 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
34,639 | -91,032 | -84,672 | -207,894 | -139,089 |
|
Non-Controlling/Minority Interests
|
-26,430 | 74,095 | 71,182 | 184,028 | 60,092 |
|
Net Income after Non-Controlling/Minority Interests
|
8,209 | -16,937 | -13,490 | -23,866 | -78,997 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
0 | -- | 0 | 0 | 72,134 |
|
Net Income Available to Common Stockholders
|
8,209 | -16,937 | -13,490 | -23,866 | -6,863 |
|
Diluted Net Income Available to Common Stockholders
|
8,209 | -16,937 | -13,490 | -23,866 | -6,863 |
| Basic EPS
|
0.10 | -0.16 | -0.14 | -0.37 | -0.13 |
| Diluted EPS
|
0.09 | -0.16 | -0.14 | -0.37 | -0.13 |
|
Basic Weighted Average Shares Outstanding
|
120,193.87 | 108,670.16 | 95,697.37 | 64,338.58 | 54,086.38 |
|
Diluted Weighted Average Shares Outstanding
|
126,671.42 | 108,670.16 | 95,697.37 | 64,338.58 | 54,086.38 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
62,514 | -78,943 | -79,683 | -212,514 | -139,089 |
|
EBITDA
|
103,750 | -34,814 | -56,203 | -201,203 | -133,100 |
|
Normalized EBITDA
|
289,327 | 147,457 | 61,692 | -17,581 | -89,762 |
|
Normalized Income
|
210,752.12 | 107,475.82 | 4,232.23 | -53,898.76 | -108,108 |
|
Total Unusual Items
|
222,928 | 202,559 | 112,537 | 157,138 | 30,981 |
9/30/2022 - 3/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade